Should We Perform a New Adjuvant Trial with Bevacizumab?

Current Colorectal Cancer Reports ◽

10.1007/s11888-011-0101-6 ◽

2011 ◽

Vol 7 (3) ◽

pp. 218-226 ◽

Author(s):

Arvind Dasari ◽

Wells A. Messersmith

Keyword(s):

Download Full-text

Randomized Surgical Adjuvant Trial of Interferon Alfa-n1 in Recurrent Papillomatosis

Archives of Otolaryngology - Head and Neck Surgery ◽

10.1001/archotol.1988.01860220097032 ◽

1988 ◽

Vol 114 (10) ◽

pp. 1163-1169 ◽

Author(s):

B. G. Leventhal ◽

H. K. Kashima ◽

P. W. Weck ◽

P. Mounts ◽

J. K. Whisnant ◽

...

Keyword(s):

Interferon Alfa ◽

Download Full-text

For a better adjuvant strategy for resected lung cancer—lessons from treatment failure patterns of the ADJUVANT trial (CTONG 1104)

Translational Lung Cancer Research ◽

10.21037/tlcr.2019.08.24 ◽

2019 ◽

Vol 8 (S4) ◽

pp. S395-S399

Author(s):

Kenichi Suda

Keyword(s):

Lung Cancer ◽

Treatment Failure ◽

Adjuvant Trial ◽

Failure Patterns

Download Full-text

Health related quality of life of women in TEACH, a randomised placebo controlled adjuvant trial of lapatinib in early stage Human Epidermal Growth Factor Receptor (HER2) overexpressing breast cancer

European Journal of Cancer ◽

10.1016/j.ejca.2015.02.005 ◽

2015 ◽

Vol 51 (6) ◽

pp. 685-696 ◽

Author(s):

Frances M. Boyle ◽

Ian E. Smith ◽

Joyce O’Shaughnessy ◽

Bent Ejlertsen ◽

Aman U. Buzdar ◽

...

Keyword(s):

Breast Cancer ◽

Quality Of Life ◽

Early Stage ◽

Growth Factor Receptor ◽

Health Related Quality ◽

Adjuvant Trial ◽

Related Quality ◽

Health Related ◽

Epidermal Growth

Download Full-text

Focal HER2/neu amplified clones partially account for discordance between immunohistochemistry and fluorescence in-situ hybridization results: data from NCCTG N9831 Intergroup Adjuvant Trial

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.568 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 568-568 ◽

Author(s):

D. V. Miller ◽

R. B. Jenkins ◽

W. L. Lingle ◽

N. E. Davidson ◽

P. A. Kaufman ◽

...

Keyword(s):

In Situ Hybridization ◽

Fluorescence In Situ Hybridization ◽

Download Full-text

A randomized, placebo-controlled, multicenter phase II adjuvant trial of the efficacy, immunogenicity, and safety of GI-4000 plus gemcitabine versus gemcitabine alone in patients with resected pancreatic cancer with activating ras mutations.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.tps226 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. TPS226-TPS226

Author(s):

S. H. Whiting ◽

P. Muscarella ◽

A. Rosemurgy ◽

W. E. Fisher ◽

D. A. Richards ◽

...

Keyword(s):

Pancreatic Cancer ◽

Phase Ii ◽

Adjuvant Trial ◽

Ras Mutations ◽

Multicenter Phase

Download Full-text

International tailored chemotherapy adjuvant trial: ITACA trial.

Journal of Clinical Oncology ◽

10.1200/jco.2011.29.15_suppl.e17514 ◽

2011 ◽

Vol 29 (15_suppl) ◽

pp. e17514-e17514 ◽

Author(s):

S. Novello ◽

G. Scagliotti ◽

V. Torri ◽

V. Monica ◽

M. Papotti ◽

...

Keyword(s):

Adjuvant Trial ◽

Chemotherapy Adjuvant

Download Full-text

Validation of tumor infiltrating lymphocytes (TIL) and tumor budding as predictors of prognosis in patients with stage III colon cancers treated in a FOLFOX-based adjuvant trial: NCCTG N0147 (Alliance).

Journal of Clinical Oncology ◽

10.1200/jco.2018.36.15_suppl.3583 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. 3583-3583

Author(s):

Frank A. Sinicrope ◽

Qian Shi ◽

Hee Eun Lee ◽

Nathan R. Foster ◽

Steven R. Alberts ◽

...

Keyword(s):

Tumor Infiltrating Lymphocytes ◽

Stage Iii ◽

Tumor Budding ◽

Adjuvant Trial ◽

Colon Cancers ◽

Infiltrating Lymphocytes

Download Full-text

The current EORTC Melanoma Cooperative Group adjuvant trial programme on malignant melanoma

Melanoma Research ◽

10.1097/00008390-199708001-00020 ◽

1997 ◽

Vol 7 (SUPPLEMENT 2) ◽

pp. S133 ◽

Author(s):

Alexander M. M. Eggermont

Keyword(s):

Malignant Melanoma ◽

Cooperative Group ◽

Download Full-text

Soluble human epidermal growth factor receptor 2 (HER2) levels in patients with HER2-positive breast cancer receiving chemotherapy with or without trastuzumab: Results from North Central Cancer Treatment Group adjuvant trial N9831

Cancer ◽

10.1002/cncr.28130 ◽

2013 ◽

Vol 119 (15) ◽

pp. 2675-2682 ◽

Author(s):

Alvaro Moreno-Aspitia ◽

David W. Hillman ◽

Stephen H. Dyar ◽

Kathleen S. Tenner ◽

Julie Gralow ◽

...

Keyword(s):

Breast Cancer ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Treatment Group ◽

Growth Factor Receptor ◽

Her2 Positive ◽

North Central ◽

Adjuvant Trial ◽

Epidermal Growth ◽

Positive Breast Cancer

Download Full-text

ERBB2 alterations a new prognostic biomarker in stage III colon cancer from a FOLFOX based adjuvant trial (PETACC8)

Annals of Oncology ◽

10.1093/annonc/mdw370.08 ◽

2016 ◽

Vol 27 ◽

pp. vi151 ◽

Author(s):

P. Laurent-Puig ◽

R. Balogoun ◽

A. Cayre ◽

K. Le Malicot ◽

J. Tabernero ◽

...

Keyword(s):

Colon Cancer ◽

Prognostic Biomarker ◽

Stage Iii ◽

Adjuvant Trial ◽

Stage Iii Colon Cancer

Download Full-text